MICHAEL DARREN BENNETT, M.D.
Medical Practice at Ala Moana Blvd, Honolulu, HI
License number
Hawaii MD10612
Category
Medical Practice
Type
Ophthalmology
Address
Address
1620 Ala Moana Blvd SUITE 500, Honolulu, HI 96815
Phone
(808) 955-0255
(808) 955-4155 (Fax)
(808) 955-4155 (Fax)
Professional information
Dr. Michael D Bennett, Honolulu HI - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Retina Institute Of Hawaii
1620 Ala Moana Blvd SUITE 500, Honolulu 96815
(808) 955-0255 (Phone)
1620 Ala Moana Blvd SUITE 500, Honolulu 96815
(808) 955-0255 (Phone)
Certifications:
Ophthalmology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Retina Institute Of Hawaii
1620 Ala Moana Blvd SUITE 500, Honolulu 96815
Pali Momi Medical Center
98 Moanalua Rd, Aiea 96701
1620 Ala Moana Blvd SUITE 500, Honolulu 96815
Pali Momi Medical Center
98 Moanalua Rd, Aiea 96701
Education:
Medical School
New York Medical College
Graduated: 1993
Emory University School Of Med
Legacy Emmanuel Hospital and Med Center
New York Medical College
Graduated: 1993
Emory University School Of Med
Legacy Emmanuel Hospital and Med Center
Process For Use Of Fluoroquinolones To Reduce Or Modulate Inflammation Due To Eye Disease Or Ophthalmic Surgery
US Patent:
2008013, Jun 12, 2008
Filed:
Oct 22, 2007
Appl. No.:
11/876435
Inventors:
Michael D. Bennett - Honolulu HI, US
International Classification:
A61K 31/4709, A61K 31/47, A61K 31/7088, A61K 39/395, A61P 27/02
US Classification:
4241451, 514311, 514314, 514 44
Abstract:
The present invention provides a safer and more effective way to treat ophthalmic disease and to perform ophthalmic surgeries while reducing the risk of vision loss due to the inflammatory response in the eye. The invention generally relates to the use of fluoroquinolones to reduce inflammation due to ophthalmic disease or ophthalmic surgery, including treatments for macular degeneration, diabetes, and vascular ischemic diseases, and other ophthalmic diseases. One aspect of the present invention involves using an anti-VEGF medication along with moxifloxacin in treating ophthalmic disease and in reducing inflammatory response in the eye following surgery for treating diseases like wet macular degeneration. Another aspect of the present invention involves delivering a fluoroquinolone combination to the eye in a sustained delivery application or device.
Michael Darren Bennett, Honolulu HI
Specialties:
Ophthalmology
Work:
Retina Institute of Hawaii
1620 Ala Moana Blvd, Honolulu, HI 96815 Retina Institute of Hawaii
98-1079 Moanalua Rd, Aiea, HI 96701 Retina Institute of Hawaii
606 Kilani Ave, Wahiawa, HI 96786 Retina Institute of Hawaii
75-167 Hualalai Rd, Kailua Kona, HI 96740
1620 Ala Moana Blvd, Honolulu, HI 96815 Retina Institute of Hawaii
98-1079 Moanalua Rd, Aiea, HI 96701 Retina Institute of Hawaii
606 Kilani Ave, Wahiawa, HI 96786 Retina Institute of Hawaii
75-167 Hualalai Rd, Kailua Kona, HI 96740
Education:
New York Medical College (1993) Ophthalmology
Michael Darren Bennett, Honolulu HI
Specialties:
Ophthalmologist
Address:
1620 Ala Moana Blvd, Honolulu, HI 96815
Education:
Doctor of Medicine
Surgical Blade And Trocar System
US Patent:
2008021, Sep 4, 2008
Filed:
Jan 28, 2008
Appl. No.:
12/020873
Inventors:
Michael D. Bennett - Honolulu HI, US
International Classification:
A61F 9/007
US Classification:
606166
Abstract:
The present invention provides an improved surgical blade and trocar system for accessing the retina and other parts of the eye while doing vitreo-retinal and cataract surgeries, including surgeries for macular degeneration. The eye surgeon uses an improved surgical blade for vitreo-retinal and cataract surgeries having a generally flat, V-shaped, W-shaped, or “extended W” shaped cross-section. Using the improved surgical blade, the surgeon creates a multi-planar, self-sealing surgical wound, first by directing the surgical blade substantially perpendicular to the eye surface, then redirecting the blade to follow the general curvature of the eye globe, and finally redirecting the blade to enter the interior of the eye. The improved surgical blade is used with an improved trocar system having two main parts-a relatively rigid, wide-mouthed outer segment and a generally thin-walled, collapsible plastic polymer or metal mesh sleeve that spans the surgical wound and substantially molds to its contour. The improved surgical blade and trocar system can be adapted for use in either vitreo-retinal or cataract surgeries.